After undergoing treatment for Stage 2 Hodgkins lymphoma, Hardee Bhavsar is on a journey to cross items off her bucket list ...
Al Unger beat aggressive lymphoma through personalized treatment, proving age doesn't limit cancer recovery with the right ...
In the global intention-to-treat population, Pola-R-CHP showed significant progression-free survival benefit over R-CHOP ...
In this video, Tycel Phillips, MD, discusses the current landscape of frontline treatment for advanced stage Hodgkin lymphoma ...
WISH-TV on MSN
New treatment for Non-Hodgkin's Lymphoma
Hungary’s László Krasznahorkai wins Nobel Prize in literature for work confronting ‘apocalyptic terror’ Government Shutdown: ...
Low-dose nivolumab (Opdivo) plus lenalidomide (Revlimid) yielded a promising response with a favorable safety profile in patients with classical Hodgkin lymphoma (cHL), according to a single-arm phase ...
Lucinda Cleland, 22, experienced chest pains that were caused by a benign cyst. After undergoing a routine surgery to remove ...
BeOne Medicines said the Food and Drug Administration has granted Breakthrough Therapy Designation for sonrotoclax for the treatment of adult patients with relapsed or refractory mantle cell lymphoma.
Every year, more than 80,000 Americans hear these life-changing words: You have non-Hodgkin’s lymphoma, a blood cancer.
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...
Medpage Today on MSN
CAR-T Drug for Myeloma Hit With New Boxed Warning
Ciltacabtagene autoleucel (cilta-cel; Carvykti) for multiple myeloma has a new boxed warning for immune effector ...
Lymphoma is one of the most common blood cancers worldwide. While there are no exact statistics for Cayman, the global burden of lymphoma makes early detection essential for better outcomes.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果